Mohawk Industries (MHK) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Q1 2026 net sales rose 8% year-over-year to $2.73 billion, with adjusted EPS of $1.90, reflecting strong operational execution and productivity gains despite a challenging environment.
Net earnings attributable to shareholders increased to $117 million, supported by tax benefits, more shipping days, and favorable FX.
Productivity, restructuring, and premium product launches improved results, with commercial outperforming residential.
Share repurchases totaled 607,000 shares for $64 million in Q1 2026, with a $500 million buyback program authorized.
Financial highlights
Adjusted operating income was $149.5 million (5.5% margin), up from $122.4 million (4.8%) year-over-year.
Gross margin was 23.5% as reported and 24.8% adjusted, up year-over-year, aided by restructuring/productivity and FX benefits.
Free cash flow for Q1 was $102.3 million; cash and equivalents at $872 million; net debt to EBITDA ratio at 0.9.
Adjusted EBITDA for Q1 2026 was $299.8 million (11.0% margin).
Adjusted tax rate was 19.4% for Q1; effective tax rate was (8.2)% due to one-time benefits.
Outlook and guidance
Adjusted EPS for Q2 2026 expected between $2.50 and $2.60, excluding restructuring or one-time charges.
Full impact of price increases and rising input costs expected in Q3; ongoing volatility from Middle East conflict and inflation may require further pricing actions.
Management expects continued market softness due to low housing turnover, high mortgage rates, and weak consumer confidence, but restructuring actions are expected to deliver $360 million in annualized benefits.
Latest events from Mohawk Industries
- Q4 2025 net sales rose 2.4% with strong cash flow; 2026 outlook expects improved earnings.MHK
Q4 202516 Apr 2026 - Annual meeting covers director elections, pay, new incentive plan, and key governance issues.MHK
Proxy filing3 Apr 2026 - Q2 adjusted EPS up 9% as cost actions and cash flow offset weak sales and market pressures.MHK
Q2 20242 Feb 2026 - Q3 2024 adjusted EPS up 7% to $2.90; 2025 recovery expected as rates decline.MHK
Q3 202418 Jan 2026 - Q1 2025 sales fell 5.7% to $2.53B; adjusted EPS $1.52; tariffs add $50M in costs.MHK
Q1 202525 Dec 2025 - Adjusted EPS steady at $1.95 as cost actions offset weak demand; $285M savings targeted.MHK
Q4 20249 Dec 2025 - Proxy covers director elections, auditor ratification, executive pay, and ESG priorities.MHK
Proxy Filing1 Dec 2025 - Q3 2025 sales up 1.4% to $2.8B, with $110M in savings and ongoing cost actions amid soft demand.MHK
Q3 202524 Oct 2025 - Flat Q2 2025 sales, margin pressure, and a $500M buyback amid ongoing cost and tariff risks.MHK
Q2 202525 Jul 2025